Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective
Antenatal facilities are ideally suited to administer vaccines to pregnant women; however, targeted educational campaigns and immunization promotion by antenatal staff will improve maternal influenza immunization coverage. There is high utilization of TTCV in South Africa, with over 99% of women receiving at least 1 dose of TTCV, which is encouraging, especially considering that South Africa is implementing a single dose of a combination tetanus-diphtheria-acellular pertussis vaccine to replace tetanus toxoid (TT) in pregnancy.
Authors
- Shaun Barnabas (ORCID: https://orcid.org/0000-0002-4819-9501)
- Jean Le Roux (ORCID: https://orcid.org/0009-0000-7229-3031)
- Clare Cutland (ORCID: https://orcid.org/0000-0001-8250-8307)
- Shobna Sawry (ORCID: https://orcid.org/0000-0002-3845-4863)
- Lee Fairlie (ORCID: https://orcid.org/0000-0001-5327-1734)
- Julia Bourne (ORCID: https://orcid.org/0000-0002-6031-7654)
Institutions
- South African Medical Research Council (ZA)
- University of the Witwatersrand (ZA)
- Stellenbosch University (ZA)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/inf.0000000000004698
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical Research Council